Health
Even low-dose oral glucocorticoid use associated with increased CV risk – medwireNews
UK research has identified a “strong dose-dependent” association between oral glucocorticoid use and CVD risk among people with immune-mediated diseases, with an…
medwireNews: UK research has identified a strong dose-dependent association between oral glucocorticoid use and cardiovascular disease (CVD) risk among people with immune-mediated diseases, with an increased risk seen even at prednisolone-equivalent doses of less than 5 mg/day.
These results highlight the importance of prompt and regular monitoring of cardiovascular risk and use of primary prevention treatment at all glucocorticoid doses, write the researchers in PLOS Medicine.
Mar Pujades-Rodriguez…
-
Noosa News17 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General20 hours agoFirst home buyers score early access to deposit scheme
-
Noosa News18 hours agoForum responds to urgent homelessness issues in Nambour
-
General17 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers